What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Enzyme
His primary areas of study are Internal medicine, Endocrinology, Dopamine, Neuroscience and Serotonin.
The concepts of his Endocrinology study are interwoven with issues in Anesthesia, Transporter and Radioligand.
As part of his studies on Dopamine, he frequently links adjacent subjects like Spect imaging.
In his research, Neurochemical is intimately related to Antidepressant, which falls under the overarching field of Serotonin.
His Positron emission tomography research is multidisciplinary, relying on both Tissue distribution, Metabolic clearance rate, Human brain, Pharmacology and In vivo.
His In vivo research incorporates themes from Receptor, Pharmacokinetics and In vitro.
His most cited work include:
- Consensus nomenclature for in vivo imaging of reversibly binding radioligands (1571 citations)
- MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. (1243 citations)
- Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects (1102 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Radioligand, Receptor and Pharmacology.
Dopamine, Striatum, Binding potential and Dopaminergic are among the areas of Endocrinology where the researcher is concentrating his efforts.
His Dopamine study combines topics from a wide range of disciplines, such as Transporter and Spect imaging.
The Radioligand study combines topics in areas such as Agonist, Positron emission tomography, Human brain and Ligand.
His research integrates issues of Neuroimaging and Pathology in his study of Positron emission tomography.
His In vivo research is multidisciplinary, incorporating elements of In vitro and Biochemistry.
He most often published in these fields:
- Internal medicine (29.66%)
- Endocrinology (28.36%)
- Radioligand (27.24%)
What were the highlights of his more recent work (between 2011-2021)?
- Radioligand (27.24%)
- Internal medicine (29.66%)
- Translocator protein (7.84%)
In recent papers he was focusing on the following fields of study:
Robert B. Innis focuses on Radioligand, Internal medicine, Translocator protein, Human brain and Positron emission tomography.
His studies in Radioligand integrate themes in fields like Lipophilicity, Metabotropic glutamate receptor 1 and Pharmacology.
His research in Internal medicine intersects with topics in Endocrinology and Prefrontal cortex.
Robert B. Innis has included themes like Rolipram and Serotonin in his Endocrinology study.
Human brain is a subfield of Neuroscience that Robert B. Innis investigates.
His Positron emission tomography study is related to the wider topic of Nuclear medicine.
Between 2011 and 2021, his most popular works were:
- Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers (349 citations)
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance (236 citations)
- In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease (218 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Dopamine
His main research concerns Internal medicine, Endocrinology, Radioligand, Translocator protein and Pharmacology.
His Internal medicine study integrates concerns from other disciplines, such as Rolipram and Abstinence.
His Endocrinology research integrates issues from Inverse agonist, Prefrontal cortex and Endocannabinoid system.
Robert B. Innis has researched Radioligand in several fields, including Positron emission tomography, Standardized uptake value and Human brain.
His Translocator protein research incorporates elements of Biomarker, Clinical Dementia Rating and Neuroscience.
His work in the fields of Disulfiram overlaps with other areas such as Loperamide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
